USPTO serial 79330376
EZ1&2
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 28, 2023
- Examiner
- GULIANO, ROBERT N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EZ1&2?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
G MATHEW LOMBARD
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP230 PARK AVE4 FLOOR WESTNEW YORK, NY 10169Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica-coated particles in liquid form; magnetic particles in liquid form; reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; reagent kits comprising chemical, biochemical and biotechnological products, other than for medical or veterinary use, for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macro molecules and biologically active materials | ACTIVE | — |
| 005 | Diagnostic agents and preparations for medical purposes; diagnostic preparations for medical and veterinary medical purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica and magnetic particles; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample materials; reagent kits comprising essential diagnostic reagents and assays for medical and veterinary diagnostic purposes, namely, chemical, biochemical and biotechnological preparations for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic preparations for medical and veterinary purposes for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biochemical and biotechnological sample materials | ACTIVE | — |
| 009 | Scientific apparatus, instruments and equipment, namely, sample preparation devices for isolation of nucleic acids and proteins for research, development and examination purposes; scientific apparatus, instruments and laboratory equipment, namely, thermocyclers and automated sample-processing platforms, not for medical use, for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; chromatography columns for laboratory use; sample preparation instruments for isolation of nucleic acid or proteins and spare parts and add-ons, namely, laboratory pipettes, laboratory pipette tips, laboratory pipette tip holders; laboratory equipment, namely, magnetic particles, thermocyclers for the purpose of performing polymerase chain reactions, homogenizers to homogenize samples for subsequent isolation of nucleic acids or proteins, vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressure | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named EZ1&2
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 28, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 28, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 28, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 10, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 10, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 21, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 22, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 8, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 16, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 16, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 15, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |